Neostigmine Methylsulfate Injection Market, By Dosage, By Indication, By Distribution Channel, By End Use, By Geography

Description

The global neostigmine methylsulfate injection market size is projected to be valued at US$ 156.7 Mn in 2023 and is projected to reach US$ 213.3 Mn by 2030, registering a CAGR of 4.5% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 156.7 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	4.50%	2030 Value Projection:	US$ 213.3 Mn

Figure 1. Global Neostigmine Methylsulfate Injection Market Share (%), by Region, 2023

Neostigmine Methylsulfate Injection Market - IMG1

Neostigmine methylsulfate injection is a cholinesterase inhibitor that is used as an adjunct in the treatment of myasthenia gravis and as an antidote in the treatment of non-depolarizing neuromuscular blocking agent toxicity in the operating room or intensive care unit setting. It acts by inhibiting the acetylcholinesterase enzyme, which normally breaks down the neurotransmitter acetylcholine at the neuromuscular junction. By inhibiting this enzyme, neostigmine methylsulfate prolongs the actions of acetylcholine, increasing neuromuscular transmission and muscle strength. It helps in the management of myasthenia gravis symptoms such as weakness of the skeletal muscles of the extremities, trunk, throat, and eyes. In overdose or sensitive patients, it can cause increased stimulation at the neuromuscular junction and produce side effects such as nausea, increased saliva, and muscle cramps.

Market Dynamics:

The increasing geriatric population will continue to fuel the growth of the global neostigmine methylsulfate injection market over the forecast period. The elderly are more susceptible to neurological conditions like myasthenia gravis, which frequently needs to be treated with injections of neostigmine methylsulfate. Rising medical expenditures will also continue to fuel the growth of the global neostigmine methylsulfate injection market over the forecast period. The growth of veterinary medicine will create new opportunities for the global neostigmine methylsulfate injection market over the forecast period. Injections of neostigmine methylsulfate are also employed in veterinary medicine, particularly for the treatment of a few neuromuscular diseases in animals. It may open up new commercial prospects to increase the use and availability of neostigmine methylsulfate injections in the veterinary industry.

Lack of knowledge and diagnosis is expected to hamper the growth of the global neostigmine methylsulfate injection market over the forecast period.

Key Features of the Study:

This report provides an in-depth analysis of the global neostigmine methylsulfate injection market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global neostigmine methylsulfate injection market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Baxter International Inc., Pfizer Inc., Fresenius Kabi AG, Boehringer Ingelheim GmbH, Mylan N.V., Novartis International AG, Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, GlaxoSmithKline plc, Sun Pharmaceutical Industries Ltd., Sandoz (a division of Novartis), Accord Healthcare Inc., Lannett Company, Inc., Mallinckrodt Pharmaceuticals, and Lupin Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global neostigmine methylsulfate injection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neostigmine methylsulfate injection market

Detailed Segmentation:

Global Neostigmine Methylsulfate Injection Market, By Dosage:
- 1 mg/mL
- 0.5 mg/mL
Global Neostigmine Methylsulfate Injection Market, By Indications:
- Myasthenia Gravis
- Reversal of Neuromuscular Blockade
Global Neostigmine Methylsulfate Injection Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Neostigmine Methylsulfate Injection Market, By End User:
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
Global Neostigmine Methylsulfate Injection Market, By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profile:
- Baxter International Inc.
- Pfizer Inc.
- Fresenius Kabi AG
- Boehringer Ingelheim GmbH
- Mylan N.V.
- Novartis International AG
- Teva Pharmaceutical Industries Ltd.
- Hikma Pharmaceuticals PLC
- GlaxoSmithKline plc
- Sun Pharmaceutical Industries Ltd.
- Sandoz (a division of Novartis)
- Accord Healthcare Inc.
- Lannett Company, Inc.
- Mallinckrodt Pharmaceuticals
- Lupin Limited

Product Code: CMI6033

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Neostigmine Methylsulfate Injection Market, By Dosage
- Neostigmine Methylsulfate Injection Market, By Indication
- Neostigmine Methylsulfate Injection Market, By Distribution Channel
- Neostigmine Methylsulfate Injection Market, By End User
- Neostigmine Methylsulfate Injection Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Drivers
Rising prevalence of diseases like myasthenia gravis and postoperative ileus requiring neostigmine
Restraints
Lack of knowledge and diagnosis
Opportunities
Growth of veterinary medicine
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Neostigmine Methylsulfate Injection Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Neostigmine Methylsulfate Injection Market, By Dosage, 2018-2030, (US$ Mn)

Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019 - 2030
Segment Trends
1 mg/mL
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
0.5 mg/mL
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

6. Global Neostigmine Methylsulfate Injection Market, By Indication, 2018-2030, (US$ Mn)

Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019 - 2030
Segment Trends
Myasthenia Gravis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Reversal of Neuromuscular Blockade
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

7. Global Neostigmine Methylsulfate Injection Market, By Distribution Channel, 2018-2030, (US$ Mn)

Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019 - 2030
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

8. Global Neostigmine Methylsulfate Injection Market, By End User, 2018-2030, (US$ Mn)

Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019 - 2030
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Specialty Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Ambulatory Surgical Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

9. Global Neostigmine Methylsulfate Injection Market, By Region, 2018-2030, (US$ Mn)

Introduction
Market Share Analysis, By Region, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Region 2019 - 2030
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East & Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
GCC
Israel
Rest of Middle East
North Africa
Central Africa
South Africa

10. Competitive Landscape

Baxter International Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Pfizer Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Fresenius Kabi AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Boehringer Ingelheim GmbH
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Mylan N.V.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Novartis International AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Teva Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Hikma Pharmaceuticals PLC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
GlaxoSmithKline plc
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Sun Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Sandoz (a division of Novartis)
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Accord Healthcare Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Lannett Company, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Mallinckrodt Pharmaceuticals
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Lupin Limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views

11. Section

Research Methodology
About us